MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4 | -99.6% | 6,190 | +232.4% | 0.00% | – |
Q3 2022 | $1,000 | -98.7% | 1,862 | -97.4% | 0.00% | – |
Q2 2022 | $79,000 | +7800.0% | 70,986 | +6935.3% | 0.00% | – |
Q1 2022 | $1,000 | -99.4% | 1,009 | -99.1% | 0.00% | – |
Q4 2021 | $177,000 | +405.7% | 111,083 | +873.3% | 0.00% | – |
Q3 2021 | $35,000 | -32.7% | 11,413 | -31.0% | 0.00% | – |
Q2 2021 | $52,000 | +116.7% | 16,535 | +124.1% | 0.00% | – |
Q1 2021 | $24,000 | – | 7,379 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |